Download PDF
Thromb Haemost 2001; 86(04): 1122-1123
DOI: 10.1055/s-0037-1616547
Letters to the Editor
Schattauer GmbH

Improved Hemoglobin Status and Reduced Menstrual Blood Loss among Female Carriers of Factor V Leiden – An Evolutionary Advantage?

Pelle G. Lindqvist
1   Departments of Obstetrics and Gynecology, Sweden
,
Bengt Zöller
2   Coagulation Disorders, Lund University, University Hospital, Malmö, Sweden
,
Björn Dahlbäck
2   Coagulation Disorders, Lund University, University Hospital, Malmö, Sweden
› Author Affiliations
Further Information

Publication History

Received 15 May 2001

Accepted 16 May 2001

Publication Date:
09 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Bertina RM, Koelemann BP, Koster T. et al. Mutation in blood coagulation factor V associated with resistance to activated protein. C. Nature 1994; 369 3475 64-7.
    CrossrefPubMedSearch in Google Scholar
  • 2 Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism charactedrized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90 (Suppl. 03) 1004-8.
    CrossrefPubMedSearch in Google Scholar
  • 3 Dahlbäck B. Blood coagulation. Lancet 2000; 355 9215 1627-32.
    CrossrefPubMedSearch in Google Scholar
  • 4 Högberg U, Broström G. The demography of maternal mortality-seven Swedish parishes in the 19th century. Int J Gynaecol Obstet 1985; 23 (Suppl. 06) 489-97.
    CrossrefPubMedSearch in Google Scholar
  • 5 Lindqvist PG, Svensson PJ, Marsal K, Grennert L, Lutherkort M, Dahlbäck B. Activated protein C resistance (FV:Q506) and pregnancy. Thromb Haemost 1999; 81: 532-7.
    Thieme ConnectPubMedSearch in Google Scholar